Influenza Diagnostics Market to Grow at 8.6% CAGR to 2021

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented into traditional and molecular diagnostic tests. The traditional diagnostic tests segment is further categorized into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays.

Click   Here   for   Complete   Report   on   Influenza   Diagnostics   Market   spread  across   127   Pages, Profiling 11 Companies and Supported with 91 Tables and 33 Figures at http://www.rnrmarketresearch.com/influenza-diagnostics-market-by-test-type-traditional-rapid-influenza-detection-test-viral-culture-dfa-serology-test-molecular-rt-pcr-nasba-lamp-samba-end-user-hospital-clinic-reference-lab-poc-ho-st-to-2021-market-report.html .

In 2016, the RIDT segment is expected to account for the largest share of the traditional tests market owing to factors such as its user-friendliness, rapid generation of results, and easy interpretability. The molecular diagnostic tests segment is further divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), and simple amplification-based assays (SAMBA).In 2016, the RT-PCR segment is expected to hold the largest share of the molecular diagnostic tests market due to its ability to detect and distinguish between influenza A and B viruses with high specificity.

Premium Insights

1 Influenza Diagnostics: Market Overview

2 Geographic Analysis: Traditional Diagnostic Tests Market, By Type (2016)

3 Molecular Diagnostic Tests Market Size, By Type, 2016 vs 2021 (USD Million)

4 Life Cycle Analysis, By Region (2016)

9 Competitive Landscape

1 Overview

2 Leading Players in the Market

3 Competitive Situation and Trends

4 Product Launches and Approvals

5 Acquisitions

6 Expansions

7 Collaborations and Agreements

On the basis of end user, the influenza diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, and other end users (point-of-care testing, home health agencies, and nursing homes). The hospitals/clinical laboratories end-user segment is expected to dominate the influenza diagnostics market in 2016.

Click Here for Sample Papers of  influenza  diagnostics  market  with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=169491 .

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, the European region is expected to account for the largest share of the market due to the rapidly increasing prevalence of influenza and rise in aging population in Europe.

List of Tables

1 Global Influenza Diagnostics Market Summary

2 Market Size, By Test Type, 2014–2021 (USD Million)

3 Influenza Diagnostics Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)

4 Market Size for Traditional Diagnostic Tests, By Region, 2014–2021 (USD Million)

5 North America: Market Size for Traditional Diagnostic Tests, By Country, 2014–2021 (USD Million)

6 Europe: Market Size for Traditional Diagnostic Tests, By Country, 2014–2021 (USD Million)

7 Influenza Diagnostics Market Size for RIDT, By Region, 2014–2021 (USD Million)

8 North America: Market Size for RIDT, By Country, 2014–2021 (USD Million)

9 Europe: Market Size for RIDT, By Country, 2014–2021 (USD Million)

10 Influenza Diagnostics Market Size for Viral Culture, By Region, 2014–2021 (USD Million)

This report studies the influenza diagnostics market based on test type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

Click Now for More Details on “Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) – Global Forecast to 2021” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=891283 .

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

Request for call back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.